MZ7-mel - Cell Line (ID:51006)
HMS LINCS ID: | 51006 |
Name: | MZ7-mel |
Alternative Names: | |
LINCS ID: | LCL-1279 |
Alternative ID: | CLO_0037133 |
Parent Cell Line: | |
Reference Source: | Thomas Woelfel (Johannes Gutenberg University Mainz) |
Organism: | Homo sapiens |
Organ: | skin |
Tissue: | |
Cell Type: | |
Details of Cell Type: | |
Donor Sex: | female |
Donor Age: | |
Donor Ethnicity: | |
Donor Health Status: | |
Disease: | DOID:1909, malignant melanoma |
Details of Disease: | |
Production Details: | |
Genetic Modification(s): | none |
Known Mutations: | |
Citation Information for Mutations: | COSS753596 |
Verification Reference Profile: | |
Growth Properties: | adherent |
Recommended Culture Conditions: | |
Relevant Citations: | |
Usage Note: | |
Comments: | |
Date Publicly Available: | 2012-07-31 |
Most Recent Update: | 2016-07-12 |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20217 | Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging | Microscopy/Imaging |
20218 | Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by Reverse Phase Protein Arrays (RPPA) | Reverse Phase Protein Array |
20229 | PLSR model loadings (pMEK and pERK included) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | Analysis |
20230 | PLSR model loadings (pMEK and pERK excluded) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | Analysis |
20231 | Average variable importance in the projection (VIP) scores from the PLSR models analyzing the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines | Analysis |
20272 | Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) | Microscopy/Imaging |
20273 | Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) | Microscopy/Imaging |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Catalog ID | Provider Batch ID |
---|---|---|---|
51006-1 | Nathan Moerke (Harvard Medical School) | ||
51006-2 | Nathan Moerke (Harvard Medical School) | ||
51006-3 | Nathan Moerke (Harvard Medical School) |